DCL-1 Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP6522c
Background:
CD302 is a C-type lectin receptor involved in cell adhesion and migration, as well as endocytosis and phagocytosis.
Other Names:
CD302 antigen, C-type lectin BIMLEC, C-type lectin domain family 13 member A, DEC205-associated C-type lectin 1, Type I transmembrane C-type lectin receptor DCL-1, CD302, CD302, CLEC13A, DCL1, KIAA0022
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6522c was selected from the Center region of human DCL-1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CD302
Gene ID: 9936
Primary Accession: Q8IX05
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
CD302 is a C-type lectin receptor involved in cell adhesion and migration, as well as endocytosis and phagocytosis.
Other Names:
CD302 antigen, C-type lectin BIMLEC, C-type lectin domain family 13 member A, DEC205-associated C-type lectin 1, Type I transmembrane C-type lectin receptor DCL-1, CD302, CD302, CLEC13A, DCL1, KIAA0022
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6522c was selected from the Center region of human DCL-1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CD302
Gene ID: 9936
Primary Accession: Q8IX05
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review